Development and testing of a virtual reality tool to support recovery in people after they have left intensive care

Not Applicable

• Conditions: Perioperative medicine and pain management; Not Applicable

• Registration Number: ISRCTN88854487
• Lead Sponsor: Cwm Taf University Health Board

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-08-18
• Last Update Posted: 28 August 2023
• Study Completion: 2025-08-31

Recruitment & Eligibility

• Status: Ongoing
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Phase 1 focus groups:
1. People with a previous admission to critical care within the last five years
2. Family members/ carers of a patient with a previous admission to critical care in the last five years
3. NHS employees involved in the care of critical care patients in ICU
4. NHS employees involved in the care and recovery of patients discharged from critical care (e.g. physiotherapists,
psychologists, occupational therapists etc.)

Phase 3 feasibility study:
1. Adults with capacity to consent
2. Recent (within 4 weeks) admission to critical care requiring organ support for more than 48 hours
3. Any phase 1 participant that wishes to trial the intervention in phase 3 will be allowed to do so

Exclusion Criteria

Phase 1 focus groups:
1. Any person unable to provide informed consent
2. Any person unable to communicate in English

Phase 3 feasibility study:
1. Any person with a recent critical care admission still experiencing ongoing issues with delirium
2. A history of severe motion sickness
3. A history of photosensitive epilepsy
4. Any physical or anatomical contraindications to using VR headsets (e.g. severe visual or hearing impairment, major
skull or facial surgery)
5. Any person unable to communicate in English

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The primary outcome for the Phase 3 study is feasibility and acceptability as determined by; recruitment, retention, intervention adherence and data completion measured using patient records at the end of the study

Secondary Outcome Measures

Name	Time	Method
The secondary outcomes to be included will be decided as part of Phase 1 activities and these will be updated on the conclusion of Phase 1 and phase 2. They are expected to include:<br>1. A quality of life measure, such as the EQ-5D or ICECAP-A<br>2. A measure of psychological well-being such as the hospital anxiety and depression scale (HADS)<br>3. General well-being scale<br>4. Sleep measure <br>5. A healthcare resource use measure <br>6. A measure of cognitive performance such as the Montreal Cognitive Assessment (MOCA)<br>